Skip to content
healthcare.dev

Fycompa

NDC 62856-290, perampanel, suspension, from Eisai Inc..

Product NDC
62856-290
Status
Listed
Labeler
Eisai Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208277
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62856-290 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PERAMPANEL.5 mg/mL

Pharmacologic classes

AMPA Receptor Antagonists [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]; UGT1A9 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]

Package NDCNDC-11Package
62856-290-3862856029038340 mL in 1 BOTTLE (62856-290-38)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/71cf3309-e182-473c-8b0b-280cabd0e122

Use it

Look up 62856-290 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62856-290 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62856-290. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.